Ojer Pharma

Ojer Pharma is a Spanish pharmaceutical company specializing in the development of innovative dermatological products using advanced topical delivery technologies. Founded as a spin-off from the University of Navarra, the company focuses on high-value niche markets within dermatology, including infectious and inflammatory skin diseases. Their core expertise lies in bioadhesive formulations that enhance the efficacy and safety of active ingredients by improving skin penetration and residence time. Ojer Pharma's portfolio includes treatments for impetigo, atopic dermatitis, and fungal infections, with several products reaching the commercial or late-clinical stage.